Notably, although the combination therapy of IgBD-TRAIL and PDT induced transient body weight decrease in mice bearing CRC tumor grafts (Figure S13), the biosafety of this combination strategy should be further evaluated in future. Here, TNFSF10 is linked to colorectal carcinoma.